Editor-in-Chief
Dimitri P. Mikhailidis, MD, FFPM, FRCP, FRCPath
Reader and Academic Head, Department of Clinical Biochemistry
Royal Free Hospital and University College Medical School
London, UK
Dr Mikhailidis has disclosed that he is the recipient of sponsorship funding to attend meetings on behalf of Merck and Sharpe & Dohme; is a consultant for Merck and Sharpe & Dohme; and is a member of the speakers bureaux for Merck, Sharpe & Dohme and Genzyme.
Editorial Board
Anthony H. Barnett, MD, FRCP
Professor of Medicine, Honorary Consultant Physician
University of Birmingham Medical School
Birmingham, UK
Prof. Barnett has disclosed that he is a recipient of research/grant funding from sanofi-aventis, Eli Lilly, NovoNordisk, Merck, Sharpe & Dohme , Takeda, Pfizer and Servier; is a consultant/advisor to sanofi-aventis, Eli Lilly, NovoNordisk, MSD, Novartis, BMS-AstraZeneca ,Takeda, Boehringer Ingelheim and Servier; and is a member of the speaker's bureaus for sanofi-aventis, Eli Lilly, NovoNordisk, Merck, Sharpe & Dohme, Novartis, BMS-AstraZeneca, Takeda and Boehringer Ingelheim.
Anthony S. Wierzbicki, DPhil, DM, FRCPath
Consultant in Metabolic Medicine and Chemical Pathology and Senior Lecturer
King's, Guy's & St. Thomas' Medical School, St. Thomas' Hospital Campus
London, UK
Dr Wierzbicki has disclosed that he is a member of the speakers bureau for Aegerion.
Bradley C. Martin, PharmD, PhD
Professor and Director of Pharmaceutical Evaluation and Policy
University of Arkansas Medical Sciences
Little Rock, AK, USA
Prof. Martin has disclosed that he is a consultant/advisor for Daiichi Sankyo.
Gerard Stansby, MA, FRCS, MChir
Professor of Vascular Surgery and Honorary Consultant in Vascular Surgery
School of Surgical & Reproductive Sciences, Newcastle University
Newcastle, UK
Prof. Stansby has disclosed that he has no relevant financial relationship.
Ian Hindmarch, PhD, CPsychol, FBPsS, FFPM, FRSA
Emeritus Professor of Human Psychopharmacology
University of Surrey
Dover, UK
Prof. Hindmarch has disclosed that he is a recipient of research/grant funding for Solvay (Abbott); is a member of the speakers bureaus for sanofi-aventis, Solvay (Abbott) and GlaxoSmithKline; and is a stock shareholder in Astra-Zeneca and GlaxoSmithKline.
Jean-Yves Reginster, MD, PhD
President and Chairman, Department of Public Health Sciences,
University of Liège,
Belgium
Dr Reginster has disclosed that he is a recipient of consulting and advisory board fees from Servier, Novartis, Negma, Eli Lilly, Wyeth, Amgen, GlaxoSmithKline, Roche, Merck, Nycomed, NPS, Theramex and UCB. He has received fees for speaking at invited lectures from Merck Sharp and Dohme, Elli Lilly, Rottapharm, IBSA, Genevrier, Novartis, Servier, Roche, GlaxoSmithKline, Teijin, Teva, Ebewee Pharma, Zodiac, Analis, Theramex, Nycomed, Novo-Nordisk and Nolver, and has received grant support from Bristol Myers Squibb, Merck Sharp & Dohme, Rottapharm, Teva, Eli Lilly, Novartis, Roche, GlaxoSmithKline, Amgen, Servier.
John Plevris, MD, FRCPEd, PhD
Consultant Physician and Senior Lecturer, Endoscopy Unit, Royal Infirmary of Edinburgh
University of Edinburgh
Edinburgh, UK
Dr Plevris has disclosed that he is a recipient of research/grant funding from Imotech/Fujinon.
Michael Iskedjian, MSc
President, PharmIdeas Research and Consulting
Oakville, ON, Canada
Mr Iskedjian has disclosed that he is a consultant/advisor to Amgen Inc., Ipsen Pharma, Nestle Nutrition Institute, Pfizer Inc., Sanofi Pasteur, Sepracor and Vertex Pharmaceuticals; has invested in the past, and may continue to invest in, broad mutual funds which from time to time may hold stock in pharmaceutical companies; and is an employee of PharmIdeas Research and Consulting.
Moses S. Elisaf, MD, FRSH, FASA
Professor of Medicine, School of Medicine
University of Ioannina
Ioannina, Greece
Prof. Elisaf has disclosed that he is a recipient of research/grant funding from MSD, Solvay and Fournier; is a consultant/advisor for MSD, Solvay and Schering Plough; and is a member of the speakers bureaus for Merck, Sharpe & Dohme, Schering Plough, Pfizer and AstraZeneca.
Sebastiano Mercadante, MD,
Anesthesia and Intensive Care Unit and Pain Relief and Palliative Care Unit
La Maddalena Cancer Center, Palliative Medicine
University of Palermo, Italy
Dr Mercadante has disclosed that he has no relevant financial relationships.
Stephen Holgate, MD, DSc, FRCP, FMedSci, FRSA
Medical Research Council Professor of Immunopharmacology
University of Southampton School of Medicine
Southampton, UK
Prof. Holgate has disclosed that he is a consultant/advisor to Novartis, Amgen, MSD, Synairgen and AltaVista; is on the speakers bureaus for Merck, Sharpe & Dohme and Novartis; and is a stock shareholder in Synairgen.
Michael Schachter, FRCP
Senior Lecturer and Honorary Consultant in Clinical Pharmacology
National Heart and Lung Institute, Imperial College London, St Mary’s Campus
London, UK
Dr Schachter has disclosed that he has no relevant financial relationships.
Vivian A. Fonseca, MD, MRCP, FACE
Tullis-Tulane Alumni Chair, Section of Endocrinology, Diabetes and Metabolism; Professor, Section of Pharmacology, Department of Medicine
Tulane University Health Science Center
New Orleans, LA, USA
Prof. Fonseca has disclosed that he is the recipient of research/grant funding from GlaxoSmithKline, Novartis, Novo-Nordisk, Takeda, Astra-Zeneca, NIH, sanofi-aventis, Eli Lilly and Daiichi-Sankyo; is a consultant to, and lecturer for, GlaxoSmithKline, Novartis, Takeda, sanofi-aventis, Eli Lilly and Daiichi Sankyo; and is on the speakers bureau for Novo Nordisk and sanofi-aventis.
International Advisory Board
Alex Z. Fu
Department of Quantitative Health Sciences
Cleveland Clinic Foundation
Cleveland, OH, USA
Dr Fu has disclosed that he is the recipient of research/grant funding from Merck & Co. Inc and is a consultant/advisor to sanofi-aventis US.
Carl V. Asche
University of Utah College of Pharmacy
Salt Lake City, UT, USA
Dr Asche has disclosed that he is the recipient of research/grant funding from Takeda, Abbott and Novartis, and that he is a consultant/advisor to sanofi-aventis.
Charles N.J. McGhee
Dept of Ophthalmology
University of Auckland
Auckland, New Zealand
Prof. McGhee has disclosed that he is an advisor for research for CODA therapeutics on an occasional basis.
Christopher Chapple
Department of Urology Research
Royal Hallamshire Hospital
Sheffield, UK
Prof. Chapple has disclosed that he is the recipient of research/grant funding from Pfizer and Allergan, and is a consultant/advisor to Pfizer, Astellas, Allergan, Novartis, Tanabe, Xertion, Recordati and ONO.
Christopher M. Blanchette
Lovelace Respiratory Research Institute
Albuquerque, NM, USA
Dr Blanchette has disclosed that he is the recipient of research/grant funding from GlaxoSmithKline, AstraZeneca, Merck, Covidien and Boehringer-Ingelheim, and is a consultant/advisor to GlaxoSmithKline, Sepracor, AstraZeneca and Novartis.
Cynthia Sanoski
Jefferson School of Pharmacy
Philadelphia, PA, USA
Dr Sanoski has disclosed that she has no relevant financial relationships.
David M. Taylor
Chief Pharmacist, Maudsley Hospital
South London and Maudsley NHS Trust
London, UK
Prof. Taylor has disclosed that he is a recipient of grants or research funding from Servier and Eli Lilly; is a consultant or advisor to Servier, Eli Lilly, AstraZeneca, sanofi aventis, Jannsen-Cilag and Lundbeck ; and is a member of the speakers bureau for Bristol Myers Squibb, Eli Lilly, Lundbeck and AstraZeneca.
Dean M. Wingerchuk
Multiple Sclerosis Clinic
Mayo Clinic
Scottsdale, AZ, USA
Dr. Wingerchuk has disclosed that he has done research for Alexion, Genzyme, Genentech, Organon, and the National Multiple Sclerosis Society.
Eric G. Boyce
Department of Pharmacy Practice
University of the Pacific
Stockton, CA, USA
Dr Boyce has disclosed that he has no relevant financial relationships.
Eva Marie Vivian
UW School of Pharmacy
University of Wisconsin-Madison
Madison, WI, USA
Dr Vivian has disclosed that she has no relevant financial relationships.
Iain C. Macdougall
King's College Hospital
London, UK
Dr MacDougall has disclosed that he is the recipient of research/grant funding from Amgen, Hoffman-La-Roche, Affymax and Vifor Pharma; is a consultant/advisor to Amgen, Affymax, Ortho Biotech Roche and Takeda; and is on the speakers bureaus for Amgen and Vifor Pharma.
J. Mark Ruscin
SIU Edwardsville School of Pharmacy
Southern Illinois University
Edwardsville, IL, USA
Prof. Ruscin has disclosed that he has no relevant financial relationships.
Joseph M. Brocavich
College of Pharmacy
St John's University
Jamaica, NY, USA
Dr Brocavich has disclosed that he is a Program Co-Director Post – Pharm. D. Pharmaeceutical Industry Fellowships in Regulatory Affairs and Clinical Drug Development – funded to the University and Dean Mangione by Forest Research Institute and Co-Director Post-Pharm. D. Pharmaceutical Industry Fellowship in Medical Information and Pharmaceutical Marketing – American Reagent. Dean Mangione is the primary grant recipient.
Judy W.M. Cheng
Massachusetts College of Pharmacy and Health Sciences
Boston, MA, USA
Prof. Cheng has disclosed that she has no relevant financial relationships.
Justin A. Vale
St Mary's Hospital
London, UK
Mr Vale has disclosed that he has no relevant financial relationships.
Karen J. Tietze
Philadelphia College of Pharmacy
University of the Sciences in Philadelphia
Philadelphia, PA, USA
Dr Tietze has disclosed that she has no relevant financial relationships.
Kathryn Blake
Research Department
Nemours Children's Clinic
Jacksonville, FL, USA
Dr Blake has disclosed that she has no relevant financial relationships.
Leo P. Semes
Dept of Optometry
University of Alabama
Birmingham, AL, USA
Prof. Semes has disclosed that he is a consultant/advisor to, and a member of the speakers bureaus for Alcon and Allergan.
Lisa E. Davis
Philadelphia College of Pharmacy
University of the Sciences in Philadelphia
Philadelphia, PA, USA
Dr Davis has disclosed that her spouse is an employee of GlaxoSmithKline.
Mary W. Lee
Chicago College of Pharmacy
Midwest University
Downers Grove, IL, USA
Dr Lee has disclosed that she is a recipient of royalties as a book editor for the American Society of Health Systems Pharmacists and is an independent contractor for the American College of Clinical Pharmacy.
Mirza D. Martinez
Puerto Rico University School of Pharmacy
San Juan, Puerto Rico
Dr Martinez has disclosed that she has no relevant financial relationships.
Moyez Jiwa
WA Centre for Cancer and Palliative Care
Curtin University of Technology
Perth, Australia
Prof. Jiwa has disclosed that he has no relevant financial relationships.
Nicholas Bellamy
Centre of National Research on Disability and Rehabilitation Medicine
Queensland University
Brisbane, Australia
Prof. Bellamy has disclosed that he is the recipient of research/grant funding from Genzyme Corporation, Merck Sharpe & Dohme through the University of Queensland; is a consultant/advisor to Servier; and is the owner of the WOMAC trademark and copyrights to WOMAC, AUSCAN, 02MS, OGI and WOMBAT health status instruments and PARIS sectogram.
Nick C. Patel
LifeSynch
Medical College of Georgia
Augusta, GA, USA
Prof. Patel has disclosed that he is the recipient of research/grant funding from Takeda and Pfizer, and is a consultant/advisor to Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, Merck and Shire.
Nigel H. Greig
Laboratory of Neurosciences
National Institute on Aging
NIH, Baltimore, MD, USA
Dr Greig has disclosed that that he is a shareholder of diversified stocks as well as some selected pharmaceutical stocks (particularly Elan and Amylin).
Olivier Bruyere
Department of Public Health, Epidemiology and Health Economics
Liege University
Liege, Belgium
Prof. Bruyère has disclosed that he is the recipient of sponsorship funding from Servier, Novartis and IBSA; is the recipient of research/grant funding from Servier, Novartis, IBSA, Rottapharm and Wyeth; and is a consultant/advisor to Servier and Rottapharm.
Paul O. Gubbins
University of Arkansas for Medical Sciences
Little Rock, AK, USA
Dr Gubbins has disclosed that he has no relevant financial relationships.
Peter Y. Liu
ANZAC Research Institute, Concord Repatriation General Hospital
University of Western Sydney
Concord, Australia
Dr Liu has disclosed that he is a recipient of research/grant funding from Bayer Schering Australia.
Serge Gauthier
Director of the Alzheimer's Disease Research Unit
McGill University
Quebec, Canada
Prof Gauthier has disclosed that he is the recipient of grants or research funding from Novartis, Eli Lilly & Company, and Sonexa Therapeutics; is a consultant or advisor to Pfizer, Lundbeck and Jannsen; and is on the speakers bureaus for sanofi-aventis, Servier and Elan.
Siegfried Kasper
Dept of General Psychiatry
Medical University of Vienna
Vienna, Austria
Prof. Kasper has disclosed that he is the recipient of sponsorship funding from AstraZeneca, Eli Lilly, Lundbeck, Bristol Myers Squibb, Sepracor, Servier, Novartis and Pfizer; is the recipient of research/grant funding from Eli Lilly, Lundbeck, Bristol-Myers Squibb, Sepracor, Servier, Novartis and Pfizer; is a consultant or advisor to Astra-Zeneca, Bristol-Myers Squibb, Eli Lilly, Lundbeck, Pfizer, Janssen Pharmaceutica, Sepracor, Servier, Pierre Fabre, Wyeth, Merck Sharpe & Dohme and Schwabe; and is a member of the speakers bureaus of Astra-Zeneca, Bristol-Myers Squibb, Eli Lilly, Lundbeck, Janssen Pharmaceuticals, Pierre Fabre, Organon, CSC, Servier, Pfizer and GlaxoSmithKline.
Stuart T. Haines
Maryland University School of Pharmacy
Baltimore, MD, USA
Dr Haines has disclosed that he has no relevant financial relationships.
Trevor J.C. Higgins
Macclesfield, Cheshire, UK
Dr Higgins has disclosed that he has no relevant financial relationships.
Paul Scuffham
Griffith University School of Medicine
Brisbane, Australia
Prof. Scuffham has disclosed that he has no relevant financial relationships.
Terry L. Seaton
St Louis College of Pharmacy
St Louis, MO, USA
Dr Seaton has disclosed that he is consultant/advisor to Ciena Healthcare Pharmacy and Therapeutics Committee.
Timothy E. Welty
Kansas University Medical Center
Kansas City, KS, USA
Prof. Welty has disclosed that he is the recipient of research/grant funding from Pfizer Pharmaceuticals.
Vasilios G. Athyros
Hippocration Hospital
Aristotle University of Thessaloniki
Thessaloniki, Greece
Prof. Athyros has disclosed that he has no relevant financial relationships.
Zhao Chen
Mel and Enid Zuckerman College of Public Health
University of Arizona
Tuscon, AZ, USA
Dr Zhao Chen has disclosed that she has no relevant financial relationships.
